Sectoral Asset Management’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Sell
69,615
-10,010
-13% -$162K 1.16% 24
2025
Q4
$1.39M Buy
79,625
+5,555
+7% +$105K 1.12% 27
2025
Q3
$1.53M Buy
74,070
+8,850
+14% +$215K 0.94% 38
2025
Q2
$1.39M Sell
65,220
-4,020
-6% -$91.7K 0.92% 40
2025
Q1
$1.34M Buy
69,240
+39,240
+131% +$787K 1.04% 26
2024
Q4
$535K Buy
30,000
+3,300
+12% +$64K 0.36% 55
2024
Q3
$585K Buy
26,700
+1,700
+7% +$23.8K 0.35% 63
2024
Q2
$195K Sell
25,000
-290,000
-92% -$1.57M 0.08% 89
2024
Q1
$1.3M Buy
315,000
+285,000
+950% +$1.13M 0.51% 56
2023
Q4
$78.3K Buy
30,000
+10,000
+50% +$20.6K 0.03% 104
2023
Q3
$37.4K Sell
20,000
-30,000
-60% -$57.2K 0.01% 122
2023
Q2
$126K Buy
50,000
+30,000
+150% +$54.8K 0.02% 121
2023
Q1
$35K Buy
+20,000
New +$54.5K 0.01% 118

Other funds holding SMMT